Objective: To study the efficacy of KLT by intrapleural injection in treating malignant pleural effusion.
目的：探讨康莱特(KLT)腔内注射对恶性胸腔积液治疗的价值。
Objective To observe the therapeutic effects of intrapleural injection of Lentinan (LNT) in the treatment of malignant effusion.
目的探索香菇多糖(LNT)腔内注射对恶性胸腔积液的治疗价值。
AIM: to observe the clinical efficacy of Nocardia rubra cell wall skeleton (n CWS) in the treatment of malignant pleural effusion by intrapleural injection.
目的：观察红色诺卡菌细胞壁骨架(NCWS)胸腔内注射治疗恶性胸腔积液的临床疗效。
Objective: To study the efficacy and safety of intrapleural injection of lobaplatin combined with endostar in treatment of lung cancer with malignant pleural effusion.
目的：研究洛铂联合重组人血管内皮抑素（恩度）治疗肺癌恶性胸腔积液的有效性和安全性。
Methods: To observe the responses, adverse reactions and peripheral blood immune indexes in 27 cases with malignant pleural effusion after the intrapleural injection of KLT.
方法：观察27例恶性胸腔积液患者腔内注射KLT后的疗效、不良反应及外周血免疫指标变化。
Conclusion the results show that intrapleural injection of Cisplatin combined with NP regimen adjuvant chemotherapy can be regarded as an effective method on malignant pleural effusions.
结论顺铂胸腔注入联合NP方案化疗治疗肺癌恶性胸腔积液可以提高疗效并且对身体损伤较小。
Conclusion the intrapleural urokinase injection can effectively dissolves the fiber partition in loculated effusions by tuberculous pleurisy and prevent pleural thickening and adhesion.
结论胸膜腔内注入尿激酶，能有效溶解结核性包裹性胸腔积液中的纤维分隔，明显降低胸膜肥厚的程度和粘连发生的机会。
Conclusion the intrapleural urokinase injection can effectively dissolves the fiber partition in loculated effusions by tuberculous pleurisy and prevent pleural thickening and adhesion.
结论胸膜腔内注入尿激酶，能有效溶解结核性包裹性胸腔积液中的纤维分隔，明显降低胸膜肥厚的程度和粘连发生的机会。
应用推荐